These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

471 related items for PubMed ID: 22295727

  • 1. Lipid-lowering treatment in hypercholesterolemic patients: the CEPHEUS Thailand survey.
    Sukonthasarn A, Homsanit M, Prommete B, Chotinaiwattarakul C, Piamsomboon C, Likittanasombat K.
    J Med Assoc Thai; 2011 Dec; 94(12):1424-34. PubMed ID: 22295727
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ, Coordinating Committee of the National Cholesterol Education Program.
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [Abstract] [Full Text] [Related]

  • 4. [Adherence to statin therapy and LDL cholesterol goal attainment in type 2 diabetics and secondary prevention patients: the role of education and knowledge].
    Yiğiner O, Ozmen N, Ozçelik F, Inanç T, Kardeşoğlu E, Uz O, Işılak Z, Aparcı M, Sahin I, Arslan E, Cebeci BS.
    Turk Kardiyol Dern Ars; 2010 Dec; 38(8):544-50. PubMed ID: 21248454
    [Abstract] [Full Text] [Related]

  • 5. Contemporary management of dyslipidemia in high-risk patients: targets still not met.
    Yan AT, Yan RT, Tan M, Hackam DG, Leblanc KL, Kertland H, Tsang JL, Jaffer S, Kates ML, Leiter LA, Fitchett DH, Langer A, Goodman SG, Vascular Protection (VP) and Guidelines Oriented Approach to Lipid Lowering (GOALL) Registries Investigators.
    Am J Med; 2006 Aug; 119(8):676-83. PubMed ID: 16887414
    [Abstract] [Full Text] [Related]

  • 6. Achieving optimal lipid goals in patients with coronary artery disease.
    Karalis DG, Subramanya RD, Hessen SE, Liu L, Victor MF.
    Am J Cardiol; 2011 Mar 15; 107(6):886-90. PubMed ID: 21247526
    [Abstract] [Full Text] [Related]

  • 7. Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals.
    Waters DD, Brotons C, Chiang CW, Ferrières J, Foody J, Jukema JW, Santos RD, Verdejo J, Messig M, McPherson R, Seung KB, Tarasenko L, Lipid Treatment Assessment Project 2 Investigators.
    Circulation; 2009 Jul 07; 120(1):28-34. PubMed ID: 19546386
    [Abstract] [Full Text] [Related]

  • 8. Intensity of lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment among the elderly before and after the 2004 National Cholesterol Education Program Adult Treatment Panel III update.
    Nichols GA, Nag S, Chan W.
    Am Heart J; 2007 Sep 07; 154(3):554-60. PubMed ID: 17719305
    [Abstract] [Full Text] [Related]

  • 9. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E, Stender S, Mata P, Sager P, Ponsonnet D, Melani L, Lipka L, Suresh R, Maccubbin D, Veltri E, Ezetimibe Study Group.
    Am Heart J; 2004 Sep 07; 148(3):447-55. PubMed ID: 15389231
    [Abstract] [Full Text] [Related]

  • 10. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
    Ose L, Shah A, Davies MJ, Rotonda J, Maccubbin D, Tribble D, Veltri E, Mitchel Y.
    Curr Med Res Opin; 2006 May 07; 22(5):823-35. PubMed ID: 16709304
    [Abstract] [Full Text] [Related]

  • 11. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
    Glueck CJ, Aregawi D, Agloria M, Khalil Q, Winiarska M, Munjal J, Gogineni S, Wang P.
    Clin Ther; 2006 Jun 07; 28(6):933-42. PubMed ID: 16860175
    [Abstract] [Full Text] [Related]

  • 12. Centralized Pan-European survey on the undertreatment of hypercholesterolemia in patients using lipid lowering drugs--the CEPHEUS-Greece survey.
    Elisaf MS, Nikas N.
    Angiology; 2010 Jul 07; 61(5):465-74. PubMed ID: 20462896
    [Abstract] [Full Text] [Related]

  • 13. Low-density lipoprotein cholesterol goal attainment among post myocardial infarction patients on lipid lowering therapy at Siriraj outpatient clinic.
    Praipaisarnkit K, Wongpraparut N, Pongakasira R.
    J Med Assoc Thai; 2014 Mar 07; 97 Suppl 3():S147-54. PubMed ID: 24772592
    [Abstract] [Full Text] [Related]

  • 14. The CEPHEUS Pan-Asian survey: high low-density lipoprotein cholesterol goal attainment rate among hypercholesterolaemic patients undergoing lipid-lowering treatment in a Hong Kong regional centre.
    Chan RH, Chan PH, Chan KK, Lam SC, Hai JJ, Wong MK, Tam FC, Lam L, Chan CW, Lam YM, Siu DC, Tse HF, Lee SW.
    Hong Kong Med J; 2012 Oct 07; 18(5):395-406. PubMed ID: 23018067
    [Abstract] [Full Text] [Related]

  • 15. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 07; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 16. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE, Feely J, Sigurdsson EL, DISCOVERY study group.
    Clin Ther; 2004 Nov 07; 26(11):1821-33. PubMed ID: 15639694
    [Abstract] [Full Text] [Related]

  • 17. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
    Fox KM, Gandhi SK, Ohsfeldt RL, Blasetto JW, Davidson MH.
    Clin Ther; 2007 Nov 07; 29(11):2385-94. PubMed ID: 18158079
    [Abstract] [Full Text] [Related]

  • 18. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
    Daskalopoulou SS, Mikhailidis DP.
    Curr Med Res Opin; 2006 Mar 07; 22(3):511-28. PubMed ID: 16574035
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM, Gandhi SK, Ohsfeldt RL, Blasetto JW, Bays HE.
    Curr Med Res Opin; 2007 Sep 07; 23(9):2125-33. PubMed ID: 17655813
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J.
    Am J Geriatr Pharmacother; 2005 Dec 07; 3(4):218-28. PubMed ID: 16503317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.